Oncology

Prostate cancer: gut microbiome regulation may reduce radiotherapy side effects

Radiotherapy against prostate cancer may cause serious intestinal side effects. We discussed the impact of the local microbiota with Miguel Reis Ferreira.

Why we need to study tissue microbiome in cancer

The existence of a tumor microbiota have a lot of implications. We discussed this topic with Sandrine Miller-Montgomery (UC San Diego).

How gut microbes contribute to chemotherapy-induced pain

Researchers have started to figure out how the gut microbiota contributes to the development of peripheral neuropathy, a common side-effect of chemotherapy.

Microbiota could contribute to skin damage in some cancer therapies

A new study published in Science Translational Medicine reveals why EGFR inhibitors, which are approved to treat cancers such as lung and colorectal cancer, cause severe skin side effects.

Gut microbes activate plant-derived compounds that protect against cancer

Specific gut bacteria can activate plant-derived compounds that protect against cancer, according to a study published in Nature Microbiology.

Some fungi could increase the risk of pancreatic cancer

Certain fungi move from the gut to the pancreas, where they can trigger pancreatic cancer growth, according to a new study published in Nature.

Tumor bacteria could influence survival of people with pancreatic cancer

The tumor microbiota could influence the pancreatic cancer survival, the 1st report to explore the effect of tumor bacteria on clinical outcomes claims.

How engineered bacteria could help cancer therapy

Researchers have engineered bacteria that can colonize tumors and deliver immunotherapy drugs. The study was published in Nature Medicine.

MIBIOC: the 1st international conference dedicated to microbiota in oncology

"MIBIOC - The way of the microbiota in cancer" - IRCCS National Cancer Institute, Milan, 21-22th November 2019.

Immuno-oncology and the microbiome

The relationship between bacteria and cancer is more and more investigated. We discuss it with Laurence Zitvogel, oncologist at the Institut Gustave Roussy.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top